Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Bitopertin

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Disc Medicine to Submit NDA for Bitopertin in EPP
    Disc Medicine to Submit NDA for Bitopertin in EPP

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118674/0/en/Disc-Medicine-Announces-Positive-Pre-NDA-Meeting-and-Confirms-Plans-to-Submit-NDA-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP-in-October-2025.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    Disc Host Call on Ph 2 FDA Meeting for Bitopertin in Protoporphyria
    Disc Host Call on Ph 2 FDA Meeting for Bitopertin in Protoporphyria

    01 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/01/2973535/0/en/Disc-Medicine-to-Host-Conference-Call-on-End-of-Phase-2-FDA-Meeting-for-Bitopertin-in-Erythropoietic-Protoporphyria-EPP.html

    GLOBENEWSWIRE
    01 Nov 2024
    Share Share
    Disc Medicine Reports Q2 2024 Results And Provides Business Update
    Disc Medicine Reports Q2 2024 Results And Provides Business Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926880/0/en/Disc-Medicine-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Disc Reports Topline Results from Ph 2 Study of Bitopertin in Patients with EPP
    Disc Reports Topline Results from Ph 2 Study of Bitopertin in Patients with EPP

    01 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/01/2855150/0/en/Disc-Reports-Topline-Results-from-Phase-2-AURORA-Study-of-Bitopertin-in-Patients-with-Erythropoietic-Protoporphyria-EPP.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin
    Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin

    11 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/12/2794346/0/en/Disc-Presents-Positive-Updated-Results-from-Phase-2-BEACON-Study-of-Bitopertin-and-Other-Programs-at-the-65th-American-Society-of-Hematology-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    11 Dec 2023
    Share Share
    Disc Medicine Announces First Patient Enrolled in Phase 1/2 Trial of Bitopertin
    Disc Medicine Announces First Patient Enrolled in Phase 1/2 Trial of Bitopertin

    27 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/27/2712248/0/en/Disc-Medicine-Announces-First-Patient-Enrolled-in-Phase-1-2-Clinical-Trial-of-Bitopertin-in-Diamond-Blackfan-Anemia-DBA.html

    GLOBENEWSWIRE
    27 Jul 2023
    Share Share